Cargando…
A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604)
BACKGROUND: Standard chemotherapy for poor-prognosis metastatic nonseminoma has remained bleomycin, etoposide, and cisplatin (BEP) for many years; more effective regimens are required. OBJECTIVE: To explore whether response rates with a new intensive chemotherapy regimen, CBOP/BEP (carboplatin, bleo...
Autores principales: | Huddart, Robert A., Gabe, Rhian, Cafferty, Fay H., Pollock, Philip, White, Jeff D., Shamash, Jonathan, Cullen, Michael H., Stenning, Sally P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410298/ https://www.ncbi.nlm.nih.gov/pubmed/25001888 http://dx.doi.org/10.1016/j.eururo.2014.06.034 |
Ejemplares similares
-
Is CBOP/BEP an alternative to BEP for patients with poor prognosis metastatic germ cell tumours?
por: Addeo, A, et al.
Publicado: (2016) -
Accelerated BEP: a phase I trial of dose-dense BEP for intermediate and poor prognosis metastatic germ cell tumour
por: Rimmer, Y, et al.
Publicado: (2011) -
Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II trial (ISRCTN53643604)
por: Cafferty, Fay H., et al.
Publicado: (2020) -
Possible hybridization schemes for BEPS
por: Grant, A
Publicado: (1972) -
DDX4-EGFP transgenic rat model for the study of germline development and spermatogenesis (†)
por: Gassei, Kathrin, et al.
Publicado: (2017)